| Product Name | BCR-ABL P230 Gene Quantification Test Kit (Fluorescent PCR Method) |
| Catalog No. | BDDK-HMM-0020 |
| Description | Ph chromosome or BCR/ABL1 b2a2 and b3a2 types have become the main diagnostic criteria for CML, with ela2 predominantly seen in ALL. In 55% of CML cases b3a2 type and 40% b2a2 type. In 5% of cases both b3a2 and b2a2 type spliceosomes are present. In addition, the BCR/ABL1 fusion gene type e19a2 is present in a very small number of Ph+ CML patients, the BCR/ABL1 fusion gene is type P210 in 30-50% of adult Ph+ ALL, 20-30% of pediatric Ph+ ALL cases, and in 60% of Ph+ ALL patients the BCR/ABL1 fusion gene is type P190. |
| Disease Type | Leukaemia |
| Applications | This kit is for quantitative detection of BCR-ABL1 fusion gene type P230 (e19a2) by fluorescence quantitative PCR. |
| Sample Type | Peripheral blood |
| Detection Methods | Fluorescent PCR Method |
| Storage | -20°C |
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
